Navigation Links
Flesh-eating bacteria escape body's safety net

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that so-called flesh-eating "Strep" bacteria use a specific enzyme to break free of the body's immune system, a finding which could potentially lead to new treatments for serious infections in human patients.

The research, reported in the February 21, 2006 issue of the journal Current Biology, focuses on the major human pathogen group A Streptococcus. Among the most important of all bacterial pathogens, strep is responsible for a wide range of diseases ?from simple throat and skin infections to life-threatening conditions such as necrotizing fasciitis ("flesh-eating disease") and toxic shock syndrome.

"These findings suggest a novel approach to treating serious Strep infections, such as flesh-eating disease, by assisting our body's own defense system," said senior author Victor Nizet, M.D., UCSD associate professor of pediatrics and an infectious diseases physician at Children's Hospital, San Diego.

The UCSD investigators examined the interaction of Strep bacteria with neutrophils, specialized white blood cells that play a front line role in human's immune defense against pathogenic microbes. Recent research by European investigators had shown that neutrophils are particularly effective defenders because they release "nets" composed of DNA and toxic compounds to entrap and kill invading bacteria. In the current study, the UCSD scientists proved that disease-causing Strep release an enzyme that degrades these DNA nets, thereby allowing the organism to escape the neutrophil net and spread in body tissues.

The UCSD team used a molecular genetic approach for their studies, knocking out the gene encoding the DNA-degrading enzyme from a pathogenic Strep strain that was originally isolated from a patient suffering from necrotizing fasciitis.

"Deprived of this single enzyme, the mutant Strep strain was easily killed by human neutrophils" , said lead author John Buchanan, Ph.D., research scientist in the UCSD department of pediatrics. "In addition, the mutant Strep bacteria no longer produced a spreading infection when injected into the skin of experimental mice."

The critical role of the DNA-degrading Strep enzyme was confirmed by cloning the corresponding gene into a normally non-pathogenic bacterial strain. Addition of the single gene allowed these bacteria to degrade DNA, escape neutrophil killing, and produce a spreading ulcer in the mouse infection model. Special fluorescent microscopy techniques were used to observe how the Strep enzyme dissolved the DNA nets and allowed bacteria to float away from the neutrophils.

"The experiments explain how this DNA-degrading enzyme contributes to the severe infections produced by certain strains of Strep bacteria, while simultaneously confirming just how important neutrophil DNA nets are to our normal immune defense," said Buchanan.

Recognizing the critical role played by the DNA-degrading enzyme in progression of Strep disease, the UCSD researchers examined whether it could represent a target for therapy. Mice experimentally infected with Strep were treated by injecting a chemical inhibitor of the DNA-degrading enzyme at the site of infection. A dramatic reduction in bacterial counts and tissue injury was observed following the inhibitor treatment, when compared to controls receiving a placebo.

Nizet explained that the researchers' findings could lead to novel treatments for Strep-related diseases. "Instead of attempting to kill the bacteria directly with standard antibiotics, a treatment strategy to inhibit the Strep DNA-degrading enzyme could disarm the pathogen, making it susceptible to clearance by our normal immune defenses," he said.


'"/>

Source:University of California - San Diego


Related biology news :

1. Anti-bacterial additive widespread in U.S. waterways
2. A bacterial genome reveals new targets to combat infectious disease
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Scientists discover that host cell lipids facilitate bacterial movement
5. Family trees of ancient bacteria reveal evolutionary moves
6. Drug-resistant bacteria on poultry products differ by brand
7. Programmable cells: Engineer turns bacteria into living computers
8. NASA links nanobacteria to kidney stones and other diseases
9. Substance protects resilient staph bacteria
10. Physiological effects of reduced gravity on bacteria
11. Anammox bacteria produce nitrogen gas in oceans snackbar
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... , February 21, 2017 Scientists ... for Adoption by Plastic Industry  ... STEER, creator of ... materials in the fields of plastics, pharmaceuticals, food and nutraceuticals, ... Merck, a leading science & technology company, on creating ...
(Date:2/21/2017)... DUBLIN , Feb 21, 2017 Research ... & Biopolymers Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 12.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:2/20/2017)... , Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) ... and CEO and Fabrice Orecchioni, the company,s COO, has been named ... over the past four years, Fabrice has overseen the construction, start-up ... and the management of the Mitsui JV.  Fabrice has also ... proposed China JV. ...
(Date:2/20/2017)... NEW YORK , Feb. 20, 2017 This ... Thousand by the following Product Types: Xylanase, Amylase, Cellulase, and ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the ...
Breaking Biology Technology: